1. Home
  2. AGCO vs BBIO Comparison

AGCO vs BBIO Comparison

Compare AGCO & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGCO
  • BBIO
  • Stock Information
  • Founded
  • AGCO 1990
  • BBIO 2015
  • Country
  • AGCO United States
  • BBIO United States
  • Employees
  • AGCO N/A
  • BBIO N/A
  • Industry
  • AGCO Industrial Machinery/Components
  • BBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • AGCO Industrials
  • BBIO Health Care
  • Exchange
  • AGCO Nasdaq
  • BBIO Nasdaq
  • Market Cap
  • AGCO 7.9B
  • BBIO 6.7B
  • IPO Year
  • AGCO 1992
  • BBIO 2019
  • Fundamental
  • Price
  • AGCO $97.96
  • BBIO $34.25
  • Analyst Decision
  • AGCO Hold
  • BBIO Strong Buy
  • Analyst Count
  • AGCO 11
  • BBIO 12
  • Target Price
  • AGCO $102.30
  • BBIO $57.09
  • AVG Volume (30 Days)
  • AGCO 822.8K
  • BBIO 2.9M
  • Earning Date
  • AGCO 07-29-2025
  • BBIO 04-29-2025
  • Dividend Yield
  • AGCO 1.18%
  • BBIO N/A
  • EPS Growth
  • AGCO N/A
  • BBIO N/A
  • EPS
  • AGCO N/A
  • BBIO N/A
  • Revenue
  • AGCO $10,783,700,000.00
  • BBIO $127,415,000.00
  • Revenue This Year
  • AGCO N/A
  • BBIO $89.10
  • Revenue Next Year
  • AGCO $5.57
  • BBIO $57.07
  • P/E Ratio
  • AGCO N/A
  • BBIO N/A
  • Revenue Growth
  • AGCO N/A
  • BBIO N/A
  • 52 Week Low
  • AGCO $73.79
  • BBIO $21.62
  • 52 Week High
  • AGCO $108.76
  • BBIO $39.54
  • Technical
  • Relative Strength Index (RSI)
  • AGCO 48.98
  • BBIO 50.58
  • Support Level
  • AGCO $99.38
  • BBIO $31.77
  • Resistance Level
  • AGCO $103.13
  • BBIO $33.93
  • Average True Range (ATR)
  • AGCO 2.29
  • BBIO 1.28
  • MACD
  • AGCO -0.92
  • BBIO -0.09
  • Stochastic Oscillator
  • AGCO 2.00
  • BBIO 57.14

About AGCO AGCO Corporation

Agco is a global manufacturer of agricultural equipment. Its main machine brands are Fendt, Massey Ferguson, and Valtra; its initiatives in precision agriculture have been organized under the PTx umbrella following a series of acquisitions. While a global business, Agco's sales skew heavily toward Europe/Middle East, representing 50%-60% of sales and even more of operating profits. The company is trying to increase its exposure to the larger North and South American markets. Its products are available through a global dealer network, which includes over 3,000 dealer and distribution locations and reach into over 140 countries. Additionally, Agco offers retail and wholesale financing to customers through its unconsolidated joint venture with Rabobank of the Netherlands.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: